全文获取类型
收费全文 | 20830篇 |
免费 | 1748篇 |
国内免费 | 86篇 |
专业分类
耳鼻咽喉 | 237篇 |
儿科学 | 540篇 |
妇产科学 | 412篇 |
基础医学 | 2640篇 |
口腔科学 | 260篇 |
临床医学 | 2618篇 |
内科学 | 4454篇 |
皮肤病学 | 455篇 |
神经病学 | 1379篇 |
特种医学 | 745篇 |
外科学 | 3021篇 |
综合类 | 161篇 |
现状与发展 | 1篇 |
一般理论 | 11篇 |
预防医学 | 1978篇 |
眼科学 | 610篇 |
药学 | 1496篇 |
中国医学 | 91篇 |
肿瘤学 | 1555篇 |
出版年
2024年 | 22篇 |
2023年 | 224篇 |
2022年 | 523篇 |
2021年 | 1006篇 |
2020年 | 567篇 |
2019年 | 714篇 |
2018年 | 801篇 |
2017年 | 555篇 |
2016年 | 643篇 |
2015年 | 661篇 |
2014年 | 847篇 |
2013年 | 1006篇 |
2012年 | 1550篇 |
2011年 | 1510篇 |
2010年 | 881篇 |
2009年 | 712篇 |
2008年 | 1298篇 |
2007年 | 1270篇 |
2006年 | 1124篇 |
2005年 | 1059篇 |
2004年 | 963篇 |
2003年 | 850篇 |
2002年 | 753篇 |
2001年 | 522篇 |
2000年 | 471篇 |
1999年 | 401篇 |
1998年 | 179篇 |
1997年 | 129篇 |
1996年 | 117篇 |
1995年 | 110篇 |
1994年 | 81篇 |
1993年 | 75篇 |
1992年 | 158篇 |
1991年 | 108篇 |
1990年 | 127篇 |
1989年 | 112篇 |
1988年 | 100篇 |
1987年 | 82篇 |
1986年 | 68篇 |
1985年 | 60篇 |
1984年 | 50篇 |
1983年 | 37篇 |
1982年 | 23篇 |
1981年 | 14篇 |
1980年 | 20篇 |
1979年 | 15篇 |
1978年 | 11篇 |
1977年 | 11篇 |
1976年 | 9篇 |
1975年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
Deitelzweig Steve Luo Xuemei Nguyen Jennifer L. Malhotra Deepa Emir Birol Russ Cristina Li Xiaoyan Lee Theodore C. Ferri Mauricio Wiederkehr Danny Reimbaeva Maya Barnes Geoffrey D. Piazza Gregory 《Journal of thrombosis and thrombolysis》2022,54(4):696-696
Journal of Thrombosis and Thrombolysis - 相似文献
2.
3.
Richard Kim Elaine Tan Emily Wang Amit Mahipal Dung-Tsa Chen Biwei Cao Fadzai Masawi Cindy Machado James Yu Dae Won Kim 《The oncologist》2020,25(12):e1893-e1899
Lessons Learned
- The combination of trametinib and sorafenib has an acceptable safety profile, albeit at doses lower than approved for monotherapy.
- Maximum tolerated dose is trametinib 1.5 mg daily and sorafenib 200 mg twice daily.
- The limited anticancer activity observed in this unselected patient population does not support further exploration of trametinib plus sorafenib in patients with hepatocellular carcinoma.
4.
5.
6.
HIV risk in vulnerable groups such as itinerant male street labourers is often examined via a focus on individual determinants. This study provides a test of a modified Information-Motivation-Behavioral Skills (IMB) model to predict condom use behaviour among male street workers in urban Vietnam. In a cross-sectional survey using a social mapping technique, 450 male street labourers from 13 districts of Hanoi, Vietnam were recruited and interviewed. Collected data were first examined for completeness; structural equation modelling was then employed to test the model fit. Condoms were used inconsistently by many of these men, and usage varied in relation to a number of factors. A modified IMB model had a better fit than the original IMB model in predicting condom use behaviour. This modified model accounted for 49% of the variance, versus 10% by the original version. In the modified model, the influence of psychosocial factors was moderately high, whilst the influence of HIV prevention information, motivation and perceived behavioural skills was moderately low, explaining in part the limited level of condom use behaviour. This study provides insights into social factors that should be taken into account in public health planning to promote safer sexual behaviour among Asian male street labourers. 相似文献
7.
Background
The prevalence of tobacco usage in Native American adults and adolescents is higher than any other racial or ethnic group, yet biological risk and protective factors underlying tobacco use in this ethnic group remain unknown. A genome scan for loci associated with tobacco use phenotypes was performed with data collected from a community sample of Mission Indians residing in Southwest California. 相似文献8.
9.
Sherry X Yang Richard M Simon Antoinette R Tan Diana Nguyen Sandra M Swain 《Clinical cancer research》2005,11(17):6226-6232
PURPOSE: To delineate gene expression patterns and profile changes in metastatic tumor biopsies at baseline and 1 month after treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor erlotinib in patients with metastatic breast cancer. EXPERIMENTAL DESIGN: Patients were treated with 150 mg of oral erlotinib daily. Gene expression profiles were measured with Affymetrix U133A GeneChip and immunohistochemistry was used to validate microarray findings. RESULTS: Estrogen receptor (ER) status by immunohistochemistry is nearly coincided with the two major expression clusters determined by expression of genes using unsupervised hierarchical clustering analysis. One of 10 patients had an EGFR-positive tumor detected by both microarray and immunohistochemistry. In this tumor, tissue inhibitor of metalloproteinases-3 and collagen type 1 alpha 2, which are the EGF-down-regulated growth repressors, were significantly increased by erlotinib. Gene changes in EGFR-negative tumors are those of G-protein-linked and cell surface receptor-linked signaling. Gene ontology comparison analysis pretreatment and posttreatment in EGFR-negative tumors revealed biological process categories that have more genes differentially expressed than expected by chance. Among 495 gene ontology categories, the significant differed gene ontology groups include G-protein-coupled receptor protein signaling (34 genes, P = 0.002) and cell surface receptor-linked signal transduction (74 genes, P = 0.007). CONCLUSIONS: ER status reflects the major difference in gene expression pattern in metastatic breast cancer. Erlotinib had effects on genes of EGFR signaling pathway in the EGFR-positive tumor and on gene ontology biological process categories or genes that have function in signal transduction in EGFR-negative tumors. 相似文献
10.